Search

everythinglearnresearchcommunity

for

Search:↓

Buffalo flies and Stephanofilaria nematodes cause severe skin lesions in beef cattle, and treatment should target both.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

New tools and criteria have been developed to better assess and treat pediatric lupus.

There is a significant need for better-validated quality of life tools in dermatology.

Computer-aided imaging system helps measure balding area in female pattern hair loss.

New scale reliably assesses male hair loss with female pattern.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

PRP helps tissue repair but lacks standard preparation methods.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

We need better research to improve alopecia treatment and patient care.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Genes controlling hair growth and immune response are disrupted in male pattern baldness.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Interleukin-6 may play a role in causing alopecia areata.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

These gene variations are not linked to alopecia areata in Egyptians.

The MPV/PC ratio can help assess disease activity in alopecia areata.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

Topical caffeine improves hair loss intensity, speed, and shedding, and works better with minoxidil/azelaic acid.

Trichoscopy is crucial for accurately diagnosing fibrosing alopecia in pattern distribution.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.